APA (7th ed.) Citation

MF, D., RP, H., BJVD, B., Y, S., TM, G., CL, B., & NM, B. (2023). Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): Study protocol for a prospective, multicentre, single-arm trial. BMC cancer, 23(1), 231. https://doi.org/10.1186/s12885-023-10697-6

Chicago Style (17th ed.) Citation

MF, Djodikromo, Hermens RP, Bemt BJVD, Smit Y, Govers TM, Bekker CL, and Blijlevens NM. "Patient-guided Dose Reduction of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia (RODEO Study): Study Protocol for a Prospective, Multicentre, Single-arm Trial." BMC Cancer 23, no. 1 (2023): 231. https://doi.org/10.1186/s12885-023-10697-6.

MLA (9th ed.) Citation

MF, Djodikromo, et al. "Patient-guided Dose Reduction of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia (RODEO Study): Study Protocol for a Prospective, Multicentre, Single-arm Trial." BMC Cancer, vol. 23, no. 1, 2023, p. 231, https://doi.org/10.1186/s12885-023-10697-6.